Genmab A/S (GNMSF) Long-Term Deferred Tax (2019 - 2026)
Genmab A's (GNMSF) quarterly Long-Term Deferred Tax came in at $173.0 million in Q1 2026, up 34.11% YoY from $129.0 million in Q1 2025, and up 1.17% on a QoQ basis from $171.0 million in Q4 2025.
Genmab A/S (GNMSF) Long-Term Deferred Tax (2019 - 2026) Analysis & Trends
Genmab A (GNMSF) has 6 years of Long-Term Deferred Tax data on file, last reported at $173.0 million in Q1 2026.
- Quarterly Long-Term Deferred Tax rose 34.11% year-over-year to $173.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $173.0 million (up 34.11% YoY) and the FY2025 annual result came in at $171.0 million, up 34.65% from the prior year.
- Long-Term Deferred Tax climbed to $173.0 million in Q1 2026, from $171.0 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $173.0 million in Q1 2026 to a low of $31.0 million in Q4 2023.
- A 4-year average of $126.4 million and a median of $127.0 million in 2024 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2024 — Long-Term Deferred Tax soared 309.68% — and 2026, when it surged 34.11%.
- Tracing GNMSF's Long-Term Deferred Tax over 4 years: stood at $31.0 million in 2023, then soared by 309.68% to $127.0 million in 2024, then soared by 34.65% to $171.0 million in 2025, then advanced by 1.17% to $173.0 million in 2026.
- The last three Long-Term Deferred Tax figures came in at $173.0 million (Q1 2026), $171.0 million (Q4 2025), and $127.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 173.00 Mn |
| Mar 31, 2026 | 173.00 Mn |
| Dec 31, 2025 | 171.00 Mn |
| Sep 30, 2025 | 127.00 Mn |
| Jun 30, 2025 | 127.00 Mn |
| Mar 31, 2025 | 129.00 Mn |
| Dec 31, 2024 | 127.00 Mn |
| Dec 31, 2023 | 31.00 Mn |
| Sep 30, 2020 | 236.00 |
| Dec 31, 2019 | 139.00 |
| Sep 30, 2019 | 271.24 Mn |